Explore Business Standard
58.65 (9.04%)
Report Unavailable
-24.85 (-1.55%)
Markets Move Fast. Smarter Investors Move First.Cut through the noise with sharp insights and expert-backed analysis - with The Smart Investor.Click Here
7.31 (18.36%)
Report Unavailable
299.85 (13.56%)
-9.20 (-4.98%)
Report Unavailable
Glenmark's $700 million deal with AbbVie for ISB-2001 could unlock significant upside, though analysts note the potential is already priced in, with stock surging post-announcement
Sebi's measures are necessary to align the derivatives market with its underlying cash market, as the current disconnect is unsustainable
Market outlook: According to Emkay Global Financial, surge in Nifty has pushed the valuations out of the 'attractive' territory and has left little room for further re-rating
Technical charts show that Religare and VIP can potentially rally up to 30% from here, while DMart stock can slip another 7%. These are the key levels to watch out for on these 3 stocks.
B&K Securities initiated coverage on Landmark Cars with a 'Buy' rating and a target price of ₹820 per share